Surface marker antigens in the characterization of human embryonic stem cells.
The use of cell surface antigens to characterise embryonic stem (ES) cells, and to monitor their differentiation, has had a long history, stretching back to the early studies of differentiation antigens in the haematopoietic system, and their application to teratocarcinomas and embryonal carcinoma (EC) cells in the laboratory mouse. A wide series of such antigens, which include both glycolipids and glycoproteins are now extensively used in studies of human ES cells. Many of these were first identified using both mouse and human EC cells, although the cell surface antigen phenotype of human EC and ES cells has proved to be significantly different from that of murine EC and ES cells.
Wright
Andrew J
AJ
BioServ, The University of Sheffield, Sheffield S10 2TN, UK.
Andrews
Peter W
PW
D000818:Animals; D000954:Antigens, Surface / Q000378:metabolism*; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000378:metabolism; D002454:Cell Differentiation; D054278:Embryonal Carcinoma Stem Cells / Q000166:cytology / Q000378:metabolism*; D006017:Glycolipids / Q000378:metabolism; D006801:Humans; D016256:Lewis X Antigen / Q000378:metabolism; D011509:Proteoglycans / Q000378:metabolism; D055746:Stage-Specific Embryonic Antigens / Q000378:metabolism
D000954:Antigens, Surface; D015295:Antigens, Tumor-Associated, Carbohydrate; D006017:Glycolipids; D016256:Lewis X Antigen; D011509:Proteoglycans; D055746:Stage-Specific Embryonic Antigens; C052924:stage-specific embryonic antigen-3; C066584:stage-specific embryonic antigen-4